Skip to main content

Emergent BioSolutions, feds terminate long-running pandemic preparedness contract

Emergent made the revelation as part of its third-quarter earnings, which follow an investigation that revealed that millions of doses of a Covid-19 vaccine may have been contaminated at its Baltimore manufacturing facility.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.